PBK and hepatocellular carcinoma: Moreover, inhibition of TOPK by its siRNA indeed caused p53 transcriptional activation and cell number reduction in HepG2 cells, supporting the role of TOPK inhibition in GCM-induced p53 activation and TOPK could be an effective target for HCC chemoprevention and therapy.